SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in ER Positive/HER2 Low Breast Cancer

Conditions: ER Positive/HER2 Low Breast Cancer Interventions: Drug: SHR-A1811 Injection + Adebrelimab Injection; Drug: SHR-A1811 Injection + Adebrelimab Injection; Drug: SHR-A1811 Injection Sponsors: Shengjing Hospital; Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials